Antiemetic Effects of Lerisetron in Radiation-induced Emesis in the Dog

By Gomez-de-Segura Ignacio A.   Grande Antonio G.   De Miguel Enrique  

Acta Oncologica, Vol. 37, Iss. 7-8, 1998-12 ,pp. : 759-763

Informa Healthcare

Access to resources Recommend Favorite

Antiemetic guidelines: creating a more practical treatment approach

By Koeller Jim   Aapro Matti   Gralla Richard   Grunberg Steven   Hesketh Paul   Kris Mark   Clark-Snow Rebecca  

Supportive Care in Cancer, Vol. 10, Iss. 7, 2002-10 ,pp. : 519-522

Springer Publishing Company

Access to resources Recommend Favorite

A Double-blind, Randomised Comparison of the Anti-emetic Efficacy of Two Intravenous Doses of Dolasetron Mesilate and Granisetron in Patients Receiving High Dose Cisplatin Chemotherapy

By on behalf of the European Dolasetron Comparative Study Group   Audhuy B.   Cappelaere P.   Martin M.   Cervantes A.   Fabbro M.   Riviere A.   Khayat D.   Bleiberg H.   Faraldi M.   Claverie N.  

European Journal of Cancer, Vol. 32, Iss. 5, 1996-05 ,pp. : 807-813

Elsevier

Access to resources Recommend Favorite

Prevention of Delayed Emesis Induced by Moderately Emetogenic Chemotherapy in Patients with Acute Emesis: A Pilot Study with ACTH-Depot Plus Tropisetron

By Santini D.   Vincenzi B.   Fossati C.   D'Angelillo R.M.   Patti G.   Bianco V.   Avvisati G.   Tonini G.  

Medical Oncology, Vol. 18, Iss. 2, 2001-03 ,pp. : 131-135

Humana Press, Inc

Access to resources Recommend Favorite

Continuous infusion prochlorperazine: pharmacokinetics, antiemetic efficacy, and feasibility of high-dose therapy

By Morgan Jr Robert J.   Synold Timothy   Carr Brian I.   Doroshow James H.   Womack Eleanor P.   Shibata Stephen   Somlo George   Raschko James   Leong Lucille   McNamara Mark   Chow Warren   Tetef Merry   Margolin Kim   Akman Steven   Longmate Jeff  

Cancer Chemotherapy and Pharmacology, Vol. 47, Iss. 4, 2001-04 ,pp. : 327-332

Springer Publishing Company

Access to resources Recommend Favorite